Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$57.96 - $78.12 $3.48 Million - $4.69 Million
-60,000 Reduced 15.77%
320,400 $22.6 Million
Q4 2021

Feb 02, 2022

BUY
$50.01 - $73.35 $6.52 Million - $9.56 Million
130,400 Added 52.16%
380,400 $21.3 Million
Q3 2021

Nov 01, 2021

SELL
$59.21 - $78.66 $4.14 Million - $5.51 Million
-70,000 Reduced 21.88%
250,000 $16.3 Million
Q2 2021

Aug 04, 2021

SELL
$51.39 - $66.9 $4.11 Million - $5.35 Million
-80,000 Reduced 20.0%
320,000 $20.3 Million
Q2 2020

Aug 05, 2020

BUY
$22.91 - $39.83 $2.98 Million - $5.18 Million
130,000 Added 48.15%
400,000 $14 Million
Q1 2020

May 04, 2020

BUY
$16.44 - $37.73 $4.44 Million - $10.2 Million
270,000 New
270,000 $6.86 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.